Timothy Vollmer
Neurology · Aurora, CONPI 1669485132
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (45.6%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Genentech USA, Inc. accounts for 62.5% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2022 at $48,015 and has fallen 61.7% since, to $18,371 in 2023. Among neurology clinicians in CO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 109 payments — averaging $1249.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech USA, Inc.$85K
- Genentech, Inc.$16K
- EMD Serono, Inc.$16K
- F. Hoffmann-la Roche AG$14K
- Amgen$2K
- Novartis$1K
- plus $1K from 5 others
Across 86 payments — averaging $22,202 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Genentech, Inc.$1.7M
- F. Hoffmann-la Roche AG$62K
- Roche Products Limited$53K
- Bristol Myers Squibb$23K
- Novartis$19K
- Janssen Research & Development, LLC$12K
What the payments were for
- Consulting fees$62,15446%
- Speaking & faculty fees$61,15245%
- Travel & lodging$9,3887%
- Food & beverage$3,5053%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech USA, Inc. | 54 | $85,074 |
| Genentech, Inc. | 15 | $16,400 |
| EMD Serono, Inc. | 17 | $16,288 |
| F. Hoffmann-la Roche AG | 13 | $14,183 |
| Amgen | 1 | $1,550 |
| Novartis | 1 | $1,276 |
| Bristol Myers Squibb | 3 | $976 |
| Pacira Pharmaceuticals Incorporated | 2 | $216 |
| Actelion Pharmaceuticals, Ltd | 1 | $125 |
| Sanofi | 1 | $100 |
| Nevro Corp. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OCREVUS$111,576
- Non-Covered Product$6,967
- Mavenclad$6,253
- Enspryng$1,800
- UPLIZNA$1,550
- KESIMPTA$1,276
- Ozanimod$620
- IOVERA SYSTEM$171
How this compares
$136,199 in reported general payments places this provider in the 90th percentile of 334 neurology providers in Colorado.
Other neurology in Aurora
- Jeffrey BennettAurora$605K
- Enrique AlvarezAurora$407K
- Anna ShahAurora$157K
- Simon OhAurora$112K
- Amanda PiquetAurora$106K
- Brent MorelAurora$79K
- Drew KernAurora$68K
- Ondrea TimmermannAurora$33K
- Thomas RagoleAurora$31K
- Maria NagelAurora$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.